Matteo Levisetti

Insider Reports History

Location
Boston, MA
Signature
/s/ Matteo Levisetti by Colin Sandercock, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matteo Levisetti:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cue Biopharma, Inc. Chief Medical Officer Stock Option (right to buy) 250K 21 Mar 2025 Direct

Insider Reports Filed by Matteo Levisetti

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CUE Cue Biopharma, Inc. 21 Mar 2025 1 $0 4 Chief Medical Officer 25 Mar 2025, 16:00
CUE Cue Biopharma, Inc. 05 Jun 2024 1 $0 4 Chief Medical Officer 07 Jun 2024, 16:00
CUE Cue Biopharma, Inc. 06 Mar 2024 1 $0 4 Chief Medical Officer 08 Mar 2024, 16:00
CUE Cue Biopharma, Inc. 20 Feb 2024 1 $0 4 Chief Medical Officer 22 Feb 2024, 16:00
CUE Cue Biopharma, Inc. 21 Jul 2023 1 $0 4 Chief Medical Officer 25 Jul 2023, 12:33
CUE Cue Biopharma, Inc. 17 Jan 2023 1 $0 4 Chief Medical Officer 19 Jan 2023, 15:02
CUE Cue Biopharma, Inc. 17 Jan 2023 0 $0 3 Chief Medical Officer 19 Jan 2023, 15:01